首頁 > 市場調查報告書 > 醫療設備

生技設備

分子品管市場規模、佔有率和成長分析：按產品類型、技術、測試目標類型、工作流程階段、應用、最終用戶和地區分類 - 產業預測，2026-2033年

市場調查報告書

商品編碼

2064606

分子品管市場規模、佔有率和成長分析：按產品類型、技術、測試目標類型、工作流程階段、應用、最終用戶和地區分類 - 產業預測，2026-2033年

Molecular Quality Controls Market Size, Share, and Growth Analysis, By Product Type, By Technology, By Analyte Type, By Workflow Stage, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年06月10日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球分子品管市場價值為 2.45 億美元，預計到 2033 年將從 2025 年的 2.6338 億美元成長至 4.6972 億美元，預測期（2026-2033 年）複合年成長率為 7.5%。

分子品管市場的主要驅動力是分子診斷的擴展所帶來的對可靠檢測檢驗和能力測試日益成長的需求。該市場包含標準化的參考物質、合成對照品和能力測試板，這些對於檢驗包括PCR和次世代定序在內的各種技術的性能至關重要。隨著臨床決策越來越依賴核酸分析，製造商正在積極應對監管壓力並擴展產品線。目前，市場正顯著轉向開發可量化且與患者檢體相容的對照品，從而獲得高利潤產品。分散式檢查的興起以及資源匱乏地區對檢測可及性的需求，促使儀器供應商和品管提供者將對照品與檢測相結合，這推動了市場的長期成長並拓展了服務範圍。

全球分子品管市場的促進因素

隨著分子診斷在臨床檢查室和研究機構中的應用日益廣泛，對可靠品管的需求也日益成長。這對於維持不同平台上的檢測準確性和一致性至關重要。這些品管在幫助檢查室檢驗工作流程、識別檢測漂移以及確保效能一致性方面發揮關鍵作用，尤其是在引入新檢測方法時。因此，用於培訓、能力驗證和持續監測等用途的標準化品管的需求顯著增加。隨著診斷複雜性的不斷提高，相關人員強調需要使用經過驗證的品管品，以確保病人安全、增強臨床醫生的信心並支持分子診斷服務的發展。

全球分子品管市場的限制因素

商業化分子品管的高成本對預算緊張的小規模檢查室和機構構成重大挑戰，阻礙了它們採購這些關鍵資源的能力。這種經濟負擔迫使這些機構主要關注基本營運需求，從而可能延遲在關鍵領域實施品管。此外，更換品管品的持續成本以及對兼容多種基質的品管品的需求，加劇了這些經濟壓力。因此，許多機構選擇依賴自身品管或盡量減少採購，最終導致需求分散，並降低了實施全面外部品管方案的整體意願，尤其是在資金籌措和報銷管道有限的地區。

全球分子品管市場趨勢

全球分子品管市場正經歷顯著成長，這主要得益於個人化醫療的蓬勃發展。隨著醫療保健領域朝向個人化治療方向發展，對用於支持對偶基因特異性和致突變性檢測的品管材料的需求日益成長。這項轉變促使製造商開發多樣化的參考面板和相容的對照品，以準確反映廣泛的患者基因型和新興生物標記。品管開發公司與診斷公司之間的策略合作日益普遍，旨在加強這些檢測在各種臨床環境中的實驗室檢驗。此外，這一趨勢正在加速產品客製化和服務範圍的擴展，增強臨床對精準診斷的信心，並促進標靶治療方案的更廣泛應用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Bio-Techne Corporation
QuidelOrtho Corporation
Randox Laboratories Ltd.
LGC Limited
Grifols, SA
Seegene Inc.
Hologic, Inc.
Microbix Biosystems Inc.
Qnostics Ltd.
SERO AS
Fortress Diagnostics Ltd.
Vircell, SL
Microbiologics, Inc.
SpeeDx Pty. Ltd.
Maine Molecular Quality Controls, Inc.

結論與建議

簡介目錄

Product Code: SQMIG35J2410

Global Molecular Quality Controls Market size was valued at USD 245.0 Million in 2024 and is poised to grow from USD 263.38 Million in 2025 to USD 469.72 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The molecular quality controls market is primarily driven by the increasing demand for reliable assay validation and proficiency testing due to the growth of molecular diagnostics. This market features standardized reference materials, synthetic controls, and proficiency panels essential for verifying the performance of various techniques such as PCR and next-generation sequencing. As clinical decisions increasingly rely on nucleic acid analysis, manufacturers are responding to regulatory pressures by enhancing product offerings. There's a notable shift towards developing quantified, commutable controls that emulate patient specimens, leading to higher-margin products. The rise of decentralized testing and the need for accessibility in resource-limited areas are prompting instrument vendors and quality providers to integrate controls with assays, fostering long-term growth and enhancing service offerings in the marketplace.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Quality Controls market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Quality Controls Market Segments Analysis

Global molecular quality controls market is segmented by product type, technology, analyte type, workflow stage, application, end user and region. Based on product type, the market is segmented into Independent Controls and Instrument-Specific Controls. Based on technology, the market is segmented into PCR-Based Controls, DNA Sequencing & NGS Controls, Digital PCR Controls, Isothermal NAAT Controls and Other Molecular Technologies. Based on analyte type, the market is segmented into Single-Analyte Controls and Multi-Analyte Controls. Based on workflow stage, the market is segmented into Pre-Analytical Controls, Analytical Controls and Post-Analytical Controls. Based on application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Blood Screening, Companion Diagnostics, Prenatal Testing and Other Applications. Based on end user, the market is segmented into Clinical Laboratories, Diagnostic Laboratories, Hospitals, IVD Manufacturers, Contract Research Organizations (CROs), Academic & Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Quality Controls Market

The increasing integration of molecular diagnostics in clinical laboratories and research institutions creates a heightened demand for dependable quality controls, which are essential for maintaining assay accuracy and consistency across various platforms. These quality controls play a vital role in enabling laboratories to validate their workflows, identify any assay drifts, and ensure stable performance, especially when introducing new tests. Consequently, there is a significant drive for the acquisition of standardized control materials for purposes such as training, proficiency testing, and ongoing monitoring. As the complexity of diagnostics rises, stakeholders emphasize the need for validated controls to ensure patient safety, bolster clinician trust, and support the growth of molecular testing services.

Restraints in the Global Molecular Quality Controls Market

The elevated costs associated with commercially available molecular quality controls present a significant challenge for smaller laboratories and facilities that operate within strict budget constraints, hindering their ability to procure these essential resources. This financial burden may cause these organizations to focus primarily on basic operational needs, thereby slowing the adoption of quality controls in critical segments. Additionally, the ongoing expenses related to replacing controls and the necessity for multiple matrix-matched materials further exacerbate these financial concerns. As a result, many entities opt to rely on in-house controls or minimal purchases, ultimately fragmenting demand and dampening the overall willingness to embrace comprehensive external control programs, particularly in regions where funding and reimbursement options are limited.

Market Trends of the Global Molecular Quality Controls Market

The Global Molecular Quality Controls market is experiencing significant growth, largely driven by the expansion of personalized medicine. As healthcare increasingly moves towards tailored therapies, there is a rising demand for quality control materials that cater to allele-specific and variant-sensitive testing. This shift is prompting manufacturers to create diverse reference panels and commutable controls that accurately represent a wide range of patient genotypes and emerging biomarkers. To enhance laboratory validation of these assays in varied clinical settings, strategic partnerships between quality control developers and diagnostic companies are becoming commonplace. Additionally, this trend fosters product customization and expanded service offerings, bolstering clinical confidence in precision diagnostics and facilitating the broader adoption of targeted treatment pathways.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis
Case Studies
Technology Assessment
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology

Global Molecular Quality Controls Market Size by Product Type & CAGR (2026-2033)

Market Overview
Independent Controls
Instrument-Specific Controls

Global Molecular Quality Controls Market Size by Technology & CAGR (2026-2033)

Market Overview
PCR-Based Controls
DNA Sequencing & NGS Controls
Digital PCR Controls
Isothermal NAAT Controls
Other Molecular Technologies

Global Molecular Quality Controls Market Size by Analyte Type & CAGR (2026-2033)

Market Overview
Single-Analyte Controls
Multi-Analyte Controls

Global Molecular Quality Controls Market Size by Workflow Stage & CAGR (2026-2033)

Market Overview
Pre-Analytical Controls
Analytical Controls
Post-Analytical Controls

Global Molecular Quality Controls Market Size by Application & CAGR (2026-2033)

Market Overview
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Blood Screening
Companion Diagnostics
Prenatal Testing
Other Applications

Global Molecular Quality Controls Market Size by End User & CAGR (2026-2033)

Market Overview
Clinical Laboratories
Diagnostic Laboratories
Hospitals
IVD Manufacturers
Contract Research Organizations (CROs)
Academic & Research Institutes
Others

Global Molecular Quality Controls Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Analyte Type, Workflow Stage, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Analyte Type, Workflow Stage, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Analyte Type, Workflow Stage, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Analyte Type, Workflow Stage, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Analyte Type, Workflow Stage, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbix Biosystems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qnostics Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SERO AS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortress Diagnostics Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vircell, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbiologics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SpeeDx Pty. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maine Molecular Quality Controls, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments